Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Synthetic Biology
  4. /Illumina Ventures
Illumina Ventures

Illumina Ventures

Pure DeepTechSan Diego, United StatesActiveWebsite
Stage FocusSeed, Series A, Series B+
GeographyUS
TypeCVC
Last Activity2025
Industry Focus
Industries
Synthetic BiologyBiotechMedTechAgriTech
Technical BenchStrong
Investor TypeDeepTech Purist
ExposureMostly DeepTech Investments
Bio

Illumina Ventures is the CVC of Illumina, the dominant player in DNA sequencing, managing $560M+ in total AUM with Fund III targeting $200M (reduced from an initial $300M target). Across 51 investments, the portfolio includes foundational genomics companies: Twist Bioscience, CareDx, and Sherlock Biosciences, with 1 unicorn, 2 IPOs, and 12 acquisitions. Recent 2025 investments include Attovia Ther...

Notable Investments
T
Twist Bioscience
C
CareDx
S
Sherlock
A
Arima Genomics

Similar Funds

The Production Board

The Production Board

San Francisco, United States

Pure DeepTechSynthetic BiologyAgriTechBiotechPre-SeedSeed
Flagship Pioneering

Flagship Pioneering

Cambridge, United States

Pure DeepTechSynthetic BiologyBiotechAgriTechPre-SeedSeed
CPT Capital

CPT Capital

London, United Kingdom

Pure DeepTechSynthetic BiologyAgriTechSeedSeries A
a16z Bio + Crypto (Andreessen Horowitz)

a16z Bio + Crypto (Andreessen Horowitz)

Menlo Park, United States

GeneralistSynthetic BiologyCrypto / Web3BiotechSeedSeries A
Blue Horizon

Blue Horizon

Zurich, Switzerland

DeepTech NativeSynthetic BiologyAgriTechClimate TechSeedSeries A
Newpath Partners

Newpath Partners

Boston, United States

Pure DeepTechSynthetic BiologyBiotechMedTechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.